21 CFR 211.67
Equipment cleaning and maintenance.
- Inspections citing it: 2,438
- Of those classified, ended OAI: 29%
- Last cited: FY2026
Inspections Citing It by Fiscal Year
Sites in and outside the US, FY2017 to Oct 20, 2026.
Paragraphs Cited
As FDA posts them, all years.
- 211.67(b)
- 1,110 · Written procedures not established/followed
- 211.67(a)
- 948 · Cleaning / Sanitizing / Maintenance
- 211.67(c)
- 188 · Cleaning/maintenance records not kept
- 211.67(b)(3)
- 96 · Cleaning SOPs/instructions
- 211.67(b)(5)
- 31 · Cleaning SOPs/equipment protection
- 211.67(b)(2)
- 29 · Cleaning SOPs/schedules
- 211.67(b)(6)
- 26 · Cleaning SOP/inspection
- 211.67(b)(4)
- 10 · Cleaning SOPs/equipment identification
Regulation Text
eCFR, as of Nov 6, 2026(a) Equipment and utensils shall be cleaned, maintained, and, as appropriate for the nature of the drug, sanitized and/or sterilized at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements.
(b) Written procedures shall be established and followed for cleaning and maintenance of equipment, including utensils, used in the manufacture, processing, packing, or holding of a drug product. These procedures shall include, but are not necessarily limited to, the following:
(1) Assignment of responsibility for cleaning and maintaining equipment;
(2) Maintenance and cleaning schedules, including, where appropriate, sanitizing schedules;
(3) A description in sufficient detail of the methods, equipment, and materials used in cleaning and maintenance operations, and the methods of disassembling and reassembling equipment as necessary to assure proper cleaning and maintenance;
(4) Removal or obliteration of previous batch identification;
(5) Protection of clean equipment from contamination prior to use;
(6) Inspection of equipment for cleanliness immediately before use.
(c) Records shall be kept of maintenance, cleaning, sanitizing, and inspection as specified in §§ 211.180 and 211.182.
Recently Cited Sites
Newest inspections citing this section; each opens the site- USpharma, Ltd., Co.United States · Sep 3, 2026
- Ultra Seal CorporationUnited States · Sep 3, 2026
- Steril-Gene Life Sciences Private LtdIndia · Aug 12, 2026
- Aizant Drug Research Solutions Private Ltd.India · Jul 31, 2026
- Graviti Pharmaceuticals Private LimitedIndia · Jul 28, 2026
- Fuller Industries IncUnited States · Jul 23, 2026
- Neilmed Pharmaceuticals IncUnited States · Jul 22, 2026
- I. Shay Cosmetics IncUnited States · Jul 17, 2026
- Conopco Inc. d/b/a UnileverUnited States · Jul 13, 2026
- Wasatch Product Development, LLCUnited States · Jul 10, 2026
- LifeSouth Community Blood Centers, IncUnited States · May 21, 2026
- KDC/ONE SOCAL LABORATORIES, LLCUnited States · Apr 14, 2026
Counts are inspections with posted citations that cite any paragraph of the section, once per inspection, from FDA's Data Dashboard. OAI share is over inspections FDA finally classified. Text from eCFR, the official online CFR. FDA Data Dashboard and eCFR